08 Dec
2025
01:30 E.S.T.

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL

Read more

19 Nov
2025
06:20 E.S.T.

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

Read more

07 Nov
2025
16:30 E.S.T.

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

Read more

03 Nov
2025
09:15 E.S.T.

Cellectis to Present a Development Update for eti-cel at ASH 2025

Read more

31 Oct
2025
16:30 E.S.T.

Cellectis to Report Third Quarter Financial Results on November 7, 2025

Read more

16 Oct
2025
15:00 E.S.T.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

Read more

16 Oct
2025
07:00 E.S.T.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

Read more

07 Oct
2025
02:40 E.S.T.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Read more

04 Aug
2025
16:30 E.S.T.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Read more

28 Jul
2025
16:30 E.S.T.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

Read more